These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1118 related articles for article (PubMed ID: 23603669)

  • 1. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
    J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
    Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
    World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis.
    Molinari M; Helton S
    Am J Surg; 2009 Sep; 198(3):396-406. PubMed ID: 19520354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis.
    Cho YK; Kim JK; Kim WT; Chung JW
    Hepatology; 2010 Apr; 51(4):1284-90. PubMed ID: 20099299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
    Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
    Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver resection and radiofrequency ablation of very early hepatocellular carcinoma cases (single nodule <2 cm): a single-center study.
    Zhou Z; Lei J; Li B; Yan L; Wang W; Wei Y; Cheng K
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):339-44. PubMed ID: 24150522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of navigated radiofrequency ablation for hepatocellular carcinoma in China.
    Lai Y; Li K; Li J; Liu SX
    Int J Technol Assess Health Care; 2014 Oct; 30(4):400-8. PubMed ID: 25682956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.
    Peng ZW; Liu FR; Ye S; Xu L; Zhang YJ; Liang HH; Lin XJ; Lau WY; Chen MS
    Cancer; 2013 Nov; 119(21):3812-20. PubMed ID: 23922119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study.
    Lai EC; Tang CN
    Int J Surg; 2013; 11(1):77-80. PubMed ID: 23220487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience.
    Zhang T; Zeng Y; Huang J; Liao M; Wu H
    J Surg Res; 2014 Oct; 191(2):370-8. PubMed ID: 24766727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
    Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Liu Z; Zhou Y; Zhang P; Qin H
    Surg Laparosc Endosc Percutan Tech; 2010 Jun; 20(3):130-40. PubMed ID: 20551807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
    Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
    Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
    Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma.
    Lencioni R; Della Pina C; Bartolozzi C
    Abdom Imaging; 2005; 30(4):401-8. PubMed ID: 16132439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
    Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
    Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.